Osimertinib Impurity N, with the CAS number 1932710-29-6, is a chemical compound associated with the pharmaceutical agent osimertinib, which is primarily used in the treatment of non-small cell lung cancer (NSCLC) that harbors specific mutations in the epidermal growth factor receptor (EGFR). As an impurity, it may arise during the synthesis or degradation of osimertinib and is typically characterized by its molecular structure, which includes specific functional groups that can influence its chemical behavior and stability. The compound's characteristics may include its solubility in various solvents, stability under different conditions, and potential reactivity with other chemical species. Impurities like Osimertinib Impurity N are critical to monitor in pharmaceutical formulations to ensure safety, efficacy, and compliance with regulatory standards. Analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry are often employed to identify and quantify such impurities in drug development and quality control processes.

Osimertinib Impurity N

1932710-29-6: Osimertinib Impurity N, with the CAS number 1932710-29-6, is a chemical compound associated with the pharmaceutical agent osimertinib, which is primarily used in the treatment of non-small cell lung cancer (NSCLC) that harbors specific mutations in the epidermal growth factor receptor (EGFR). As an impurity, it may arise during the synthesis or degradation of osimertinib and is typically characterized by its molecular structure, which includes specific functional groups that can influence its chemical behavior and stability. The compound's characteristics may include its solubility in various solvents, stability under different conditions, and potential reactivity with other chemical species. Impurities like Osimertinib Impurity N are critical to monitor in pharmaceutical formulations to ensure safety, efficacy, and compliance with regulatory standards. Analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry are often employed to identify and quantify such impurities in drug development and quality control processes.

Osimertinib Impurity 7

<p>Applications N-Acryloyl Osimertinib is used in the preparation of pyrimidinyl indole derivative as EGFR inhibitor for targeted therapy of cancer<br>References Rao, Y., et al.: Faming Zhuanli Shenqing (2016), CN 105777716 A 20160720<br></p>

CAS 1932710-29-6

Osimertinib Impurity N

Osimertinib Impurity 7

Ref: 4Z-A-194008

N-Acryloyl Osimertinib (>85%)

Ref: TR-A191405

N-Acryloyl Osimertinib

Ref: ST-EA-CP-O17015